- 233 -
273.
274.
275.
276.
277.
278.
279.
280.
281.
282.
283.
284.
285.
286.
287.
accompanying substances, with the total
mass)
5-APDB
0.05-0.25
(3-desoxy-MDA, ЕМА-4)
5-(2-aminopropyl)-2,3-dihydrobenzofuran
(irrespective of the existence of
accompanying substances, with the total
mass)
6-APDB
0.05-0.25
(4-desoxy-MDA, ЕМА-3)
6 - (2-aminopropyl) -2,3-dihydrobenzofuran
(irrespective of the existence of
accompanying substances, with the total
mass)
DOI
0.05-0.25
2,5-Dimethoxy-4-iodoamphetamine
(irrespective of the existence of
accompanying substances, with the total
mass)
(point repealed by HO-204-N of 20 October 2016)
25B-NBOMe
[2-(4-bromo-2,5-dimethoxyphenyl)-N-]- (2- 0.05-0.25
methoxyphenyl)-methyl]ethanamine
25B-NBOMe-Nme
[2-(4-bromo-2,5- dimethoxyphenyl)-ethyl]- 0.05-0.25
(2- methoxybenzyl)-methylamine
25B-NBOMeTF
[2-(4-bromo-2,5-dimethoxyphenyl)-ethyl]-(2- 0.05-0.25
trifluoromethoxybenzyl)-amine
25C-NBOMe
2-(4-chloro-2,5-dimethoxyphenyl)-N-(20.05-0.25
methoxybenzyl)ethanamine
25H-NBOMe
[2-(2,5-dimethoxyphenyl)-ethyl]-(20.05-0.25
methoxybenzyl)-amine
JWH-213
(5-ethylnaphthalene-1-yl)-(2-methyl-1-pentyl- 0.05-0.25
1H-indole-3-yl)-methanone
ACBM(N)-2201 TMS
N-((3s,5s,7s)-adamantane-1-yl)-1-(50.05-0.25
fluoropentyl)-N-(trimethylsilyl)-1H-indazole-3carboxamide
MBA(N)-BZ-F (AB-FUBINACA)
N-(1-carbamoyl-2-methylprop-1-yl)-1- (4- 0.05-0.25
fluorobenzyl)-1H-indazole-3-carboxamide
MBA(N)-018 (AB-PINACA)
N-(1-carbamoyl-2-methylprop-1-yl)-1-pentyl- 0.05-0.25
1H-indazole-3-carboxamide
MBA(N)-018 (AB-PINACA)-N-(2fluoropentyl)
0.05-0.25
1-(2-fluoropentyl)-1H-indazole-3-carboxylic
acid (1-carbamoyl-2-methylpropyl)-amide
MBA(N)-018 (AB-PINACA)-N-(40.05-0.25
fluoropentyl)
CDL-REF(2021)022
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
0.25-0.5
0.5
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents